Keywords: phoqus, and/diurnal, chronocort, enters, ph, uk-based, oral

Phoqus and/Diurnal's Chronocort enters Ph I

Article | 12 December 2005

Print This

Phoqus, a UK-based oral drug-delivery company, and Diurnal, a spin-out from the UK's Sheffied University, have begun Phase I clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in